Dr. Aleda A. Longwell, MD

Dr. Longwell practices at Berman Skin Institute Medical Group Inc in Los Altos, California.

Dr. Longwell's NPI, 1093960643, was assigned on November 24, 2008. Dr. Longwell graduated from University of Rochester Medical Center in 1999. Dr. Longwell's California license number on file is A86547.

Dr. Longwell's primary practice is Berman Skin Institute Medical Group Inc, at 4300 El Camino Real, Los Altos, CA 94022 in Santa Clara County. The practice phone is (650) 325-6000.

Dr. Longwell's primary practice is Berman Skin Institute Medical Group Inc in Los Altos, California. The medical group on file is Berman Skin Institute. Dmand AI also links Dr. Longwell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Longwell practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Longwell's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Longwell is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Longwell's licenses on file in 2 states: California and Illinois.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash, skin cyst and skin discoloration among the conditions Dr. Longwell treats.

CMS data shows 309 Medicare services from Dr. Longwell across 7 procedure codes in 2024, for 97 Medicare patients. Medicare paid $17,239 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Longwell in 2024. The largest group is 65 to 74, with 46 patients. 64% of them have high cholesterol, and 51% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Longwell's median patient age at 45, with 56% women.

In 2024, Dr. Longwell wrote 72 Medicare Part D claims for 32 patients. 99% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $386 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

Dr. Longwell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 475 procedures of removal of skin lesions by Dr. Longwell, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 161 general payments to Dr. Longwell from 21 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $696.

Dmand AI lists 1 award for Dr. Longwell.

Dr. Longwell graduated from University of Rochester Medical Center in 1999. Dr. Longwell is a member of ASDS.

Dr. Longwell is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.